ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024
DGSurv: Dynamic Graph-Based Multimodal Learning for Interpretable Cancer Survival Prediction.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multimodal learning in cancer research offers transformative potential for enhancing medical care and guiding clinical decisions. Most analyses rely on unimodal inputs or employ simplistic multimodal fusion techniques, which do not optimally integrate the diverse data types. Additionally, there is a critical need for enhanced interpretative methods to fully exploit the depth of multimodal patient data. To address these issues, we propose DGSurv, a novel multimodal learning approach that utilizes a graph neural network (GNN) to dynamically map inter-modality relationships for cancer survival prediction. We demonstrate the utility of our proposed approach on cancer survival prediction, highlighting its potential to inform more accurate clinical decision-making. We perform empirical evaluations on four cancer datasets from The Cancer Genome Atlas Program (TCGA) and demonstrate that DGSurv outperforms existing fusion techniques. For interpretability, our study advances multimodal cancer analysis by effectively harnessing the full spectrum of multimodal data and significantly boosting its interpretability.
Indexed as
Identifiers
41726405PMC12919551What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.